A detailed history of Alyeska Investment Group, L.P. transactions in Absci Corp stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 250,000 shares of ABSI stock, worth $752,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
250,000
Previous 250,000 -0.0%
Holding current value
$752,500
Previous $770,000 24.03%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.92 - $6.58 $292,000 - $658,000
-100,000 Reduced 28.57%
250,000 $770,000
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $1.19 Million - $2.01 Million
350,000 New
350,000 $1.99 Million
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $1.3 Million - $3.79 Million
125,000 New
125,000 $1.45 Million

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $279M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.